MEDIGUS Ltd - Entwickler von minimal-invasiven endochirurgischen Instrumenten

[strabo]

Antwort auf Beitrag Nr.: 69.379.382 von long rider am 20.09.21 19:27:13

Zitat von long rider: Erstaunliche Zahlen von Medigus. Mit Spannung erwarte ich die nächsten Monate.

Monate war richtig. Spannung auch.

Ich habe eine erste Position geordert. Medigus hat eine erstaunliche Entwicklung gemacht, die Beteiligungen sind nicht weniger geworden.
Der Umsatzanstieg ist gut, der Gesamtumsatz reißt einen noch nicht vom Hocker, aber die Vorrausetzungen die geschaffen werden sind einen 2.Blick wert.
Medigus baut sich ein regelrechtes Techportfolio auf.

News-Sammlung:
https://www.globenewswire.com/search/organization/Medigus%25…

Und die Unternehmensseite https://medigus.com/

Da stolpert man über ein Unternehmen...(Tech,Israel,Merger....) schaut nach, ob es einen Thread gibt... und von wem ist der?

Neben all den Entwicklungen könnte vor allen die Ankündigung vom 8. September Aufhorchen lassen. Dividende?

[long rider]

Erstaunliche Zahlen von Medigus. Mit Spannung erwarte ich die nächsten Monate.

https://finance.yahoo.com/news/medigus-ltd-announces-record-…

[Malecon]

Nach drei Monaten ist es wieder soweit: Bei Medigus Ltd. - ADR versucht der MACD im Daily die Signallinie nach oben zu kreuzen:





💡

[HedgefonDevil]

Medigus: Eventer Targets the Multi-billion Dollar Virtual Conference Market
Published: Feb. 23, 2021 at 9:26 a.m. ET
0
Eventer signed an exclusive license agreement with Screenz and will invest $1.5 million for the adaptation of Screenz technology
Email icon
Facebook icon
Twitter icon
Linkedin icon
Flipboard icon
Print icon
Resize icon
The MarketWatch News Department was not involved in the creation of this content.

OMER, Israel, Feb 23, 2021 (GLOBE NEWSWIRE via COMTEX) -- OMER, Israel, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS), a technology company engaged in advanced medical solutions and innovative technology, announced today that Eventer Technologies Ltd., Medigus' subsidiary (50.1%), entered the multi-billion virtual conference market by signing an exclusive licensing agreement to adopt Screenz Cross Media Ltd. technology for virtual conferences.

Screenz is a virtual entertainment and events technology company whose customer base includes Reliance Industries (a Fortune 500 company and the largest private-sector corporation in India), Fox, ABC, Disney, Univision and Viacom.

As part of the license agreement, Screenz will provide and adapt its technology to Eventer to host and broadcast virtual conferences, including an interactive player with capabilities of broadcasting, recording and interactive layers on video. By combining both companies' knowledge and technology, Eventer plans to offer innovative new solutions to the rapidly growing virtual conference market for both its current and potential customer base.

Multiple market studies referring to virtual events, virtual conferences and virtual meeting software, predict high scalability of these markets as a result of COVID-19 pandemic. According to one market study, the global virtual events market size was valued at $ 77.98 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 23.2% from 2020 to 2027. The growing popularity of Unified Communication as a Service amongst corporations, education institutes, and various other organizations across industries is expected to drive the market during the forecast period.

"2020 created many new opportunities for Eventer, with high demand for advanced technological solutions for virtual conferences and events. Eventer has an innovative technology and years of experience in providing customers with top-of-the-line solutions for online conferences, one of the most growing fields this year. We believe Eventer has the opportunity to become a key player in the market in a relatively short time," said Liron Carmel, CEO of Medigus.

In consideration for granting the license to use the technology for virtual conferences and developing the necessary adaptions, Eventer shall pay Screenz a total sum of $1,500,000. In the first five months Eventer shall pay Screenz a monthly sum of $40,000, a grace period for Eventer's planning and establishment of the operation. Following the grace period, Eventer shall pay Screenz the remaining sum of $1,300,000 in three equal payments. The adaptation of the Screenz technology is expected to be completed in the second half of 2021. Screenz shall be entitled to 8% of the revenue received from any use of the product

About Medigus

Medigus is traded on the Nasdaq Capital Market. To learn more about the company's advanced technology, please visit www.medigus.com.

Cautionary Note Regarding Forward Looking Statements

This press release may contain statements that are "Forward-Looking Statements," which are based upon the current estimates, assumptions and expectations of the Medigus' management and its knowledge of the relevant market. Medigus has tried, where possible, to identify such information and statements by using words such as "anticipate," "believe," "envision," "estimate," "expect," "intend," "may," "plan," "predict," "project," "target," "potential," "will," "would," "could," "should," "continue," "contemplate" and other similar expressions and derivations thereof in connection with any discussion of future events, trends or prospects or future operating or financial performance, although not all forward-looking statements contain these identifying words. For example, Medigus uses forward looking statements when describing the agreement between Eventer and Screenz, the anticipated use and benefit to both parties and their prospective users,that the growing popularity of Unified Communication as a Service amongst corporations, education institutes, and various other organizations across industries is expected to drive the market during the forecast period, and the belief that Eventer has the opportunity to become a key player in the market in a relatively short time. These forward-looking statements represent Medigus' expectations or beliefs concerning future events, and it is possible that the results described in this press release will not be achieved, due to inter alia the spread of COVID-19 as well as the restriction deriving therefrom. Nothing in the description herein should be understood or construed as an announcement of the consummation of the investment by Eventer in Screenz. By their nature, Forward-Looking Statements involve known and unknown risks, uncertainties and other factors which may cause future results of Medigus activity to differ significantly from the content and implications of such statements. Other risk factors affecting Medigus are discussed in detail in Medigus' filings with the Securities and Exchange Commission. Forward-Looking Statements are pertinent only as of the date on which they are made, and Medigus undertakes no obligation to update or revise any Forward-Looking Statements, whether as a result of new information, future developments or otherwise. Neither Medigus nor its shareholders, officers and employees, shall be liable for any action and the results of any action taken by any person based on the information contained herein, including without limitation the purchase or sale of Medigus' securities. Nothing in this press release should be deemed to be medical or other advice of any kind.

Investor Contact

Oz Adler
Chief Financial Officer
[phone]
[e-mail]

[Malecon]

Ja, es gab so einige News in den letzten Tagen.

[HedgefonDevil]

Die Perle wurde noch nicht entdeckt.
Eventuell mit der Marslandung des Rover von der NASA

Warum waren Anfang Dezember solche hohen Umsätze?

[long rider]

Könnte heute ein guter Tag werden.
Medigus gehört zu Silicon Wadi und da fühle ich mich als Investor am wohlsten.👍

[HedgefonDevil]

Medigus Forms Joint Venture for the Development of Urban and Logistics Electric Vehicles with EMuze Founders
Published: Feb. 19, 2021 at 8:15 a.m. ET
0
Email icon
Facebook icon
Twitter icon
Linkedin icon
Flipboard icon
Print icon
Resize icon
The MarketWatch News Department was not involved in the creation of this content.

OMER, Israel, Feb 19, 2021 (GLOBE NEWSWIRE via COMTEX) -- Former designer of Italian vehicles manufacturer, Amir Zaid and leading manufacturer of high-end scooters, E-mobility and Skiing Machines, Weijian Zhou will join Medigus,via its wholly owned subsidiary Charging Robotics, in the Joint Venture

OMER, Israel, Feb. 19, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS), a technology company engaged in advanced medical solutions and innovative technology, announced today the signing of a definitive agreement to form a joint venture, NewCo, for the development and commercialization of urban and logistics EV micro-mobility vehicles for "last mile" delivery, and cargo. The signing of the definitive agreement relating to NewCo relates to the prior announcement in November 2020 regarding the execution of the non-binding memorandum of understanding with the EMuze founders.

The joint venture partners will include Mr. Amir Zaid, and Mr. Weijian Zhou, the founders of EMuze (a privately held company that designs and develops electric mobility micro vehicles), and Medigus via its wholly owned subsidiary Charging Robotics Ltd. Mr. Zaid is one of the leading designers in the global automotive industry and who was also part of the design of Italian vehicles manufacturer and other leading international car brands. He specializes in the micro mobility vehicles market and serves as the CEO of Emuze, an innovative urban transportation company aiming to provide safer, high-level personal transportation platforms that will help expand the use of micro mobility solutions.

Mr. Weijian Zhou is a manufacturer of high-end scooters, E-mobility and Skiing Machines. Mr. Zhou's operations are equipped with advanced machining and inspection facilities, an R&D center, and a Training Institute.

The joint venture's intended focus is to develop unique EVs that have the ability to last a full working day within a single charge, to suit a heavy-duty and rigid operation and be tailored mission-specific designs as well as Hop on -Hop off modes, off-road versions and a low cost of operation.

Medigus will be entitled to acquire up to 50.1% of the NewCo's share capital upon its incorporation, on a fully diluted basis, by investing up to US$1,350,000 upon NewCo meeting certain milestones as set in the agreement. Medigus will initially invest US$250,000 within 14 days of NewCo's incorporation, resulting in its ownership of 19.99% of NewCo's share capital. An additional US$400,000 will be invested based on predefined milestones which include the finalization of a design model within two months following the initial financing and formation of NewCo, the finalization of the development of an operational model of the "PORTO" modular delivery vehicle and 3 sample "PORTO" models within six months following the initial financing, the development of built-in tracking tool with a supporting software platform within eight months following the initial financing, and the execution of two material commercial agreements or long form engagements, for pilot projects, with at least two global shipping companies for product evaluation and purchase, within eight months following the initial financing. The second investment will result in Medigus holding 37.5% of NewCo's share capital on a fully diluted basis.

Within twelve months following the completion of the second financing, but in no event later than December 31, 2022, Medigus will be entitled to invest an additional amount of US$700,000, resulting in its ownership of 50.1% of NewCo's share capital on a fully diluted basis.

About Medigus

Medigus is traded on the Nasdaq Capital Market. To learn more about the company's advanced technology, please visit www.medigus.com.

[HedgefonDevil]

MEGA NEWS-----------------strong long

[long rider]

Swing-Trader haben Medigus entdeckt. Ich glaube und hoffe, wir heben ab. 📈